Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
1.855.MyBioSource
Fax 1.858.633.0166    Email sales@mybiosource.com 
tel/fax
menu1 Home Products Ordering Company Help menu7
bottom
   MyBioSource rightarrow Recombinant Protein rightarrow FLT4  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Menu separator
separator
ELISA Kit ELISA Kit
CLIA Kit CLIA Kit
PCR Kit PCR Kit
Monoclonal Antibody Monoclonal Antibody
Polyclonal Antibody Polyclonal Antibody
Secondary Antibody Secondary Antibody
Antigen Antigen
Biochemical Biochemical
cDNA Clone cDNA Clone
siRNA siRNA
Peptide Peptide
Recombinant/Purified Protein Rec./Purified Protein

Custom ELISA Kit Custom ELISA Kit
Custom Protein Custom Protein
Custom Antibody Custom Antibody
Antibody Matched Pairs Antibody Matched Pairs
Antibody & Corresponding Blocking Peptide Pairs Antibody Peptide Pairs
Phospho-Specific Antibodies Phospho Antibodies
Products by Disease Products by Disease
Products by Pathway Products by Pathway
Products by Tissue Products by Tissue

arrow Advanced Search
arrow Submit Technical Q&A
arrow International Distributors
arrow Contact Us
separator
Our Best Sellers moreseparator
separator
 • HIST1H2AG Antibody
 • DNAJC17 Antibody
 • M-Calpain (LOC100135837) Antibody
 • Toxoplasma Gondii P29 Recombinant Protein
 • hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) ... ELISA Kit
 • p300 (Phospho-Ser89) Antibody
 • Pak3 Blocking Peptide
 • Toxoplasma gondii Inflammatory profilin (PRF) Antibody
 • Alpha Synuclein oligomer (AlphaSYNo) ELISA Kit
 • A Disintegrin And Metalloproteinase With Thrombospondin 1 (A... ELISA Kit
 • Uncoupling Protein 1, Mitochondrial (UCP1) ELISA Kit
 • S-100 ELISA Kit
 • ATP7A (ATP7A ) Peptide
 • 3-hydroxy-3-methylglutaryl- coenzyme A reductase (HMGCR) Recombinant Protein
 downarrow more ...
separator
separator
DatasheetFull DatasheetPrinter Friendly DatasheetPrint This DatasheetAdd to Compare ListHave Questions? Ask UsRequest for a Quotation today

FLT4 recombinant protein :: Vascular Endothelial Growth Factor receptor-3 Recombinant Protein

Scan QR to view Datasheet Catalog #    MBS142790 FLT4 recombinant protein
Unit / Price
0.002 mg  /  $140 +1 FREE 8GB USB
0.01 mg  /  $205 +1 FREE 8GB USB
1 mg  /  $5,015 +6 FREE 8GB USB
 
 Go to:   rightarrow  Product Names   rightarrow Product Info   rightarrow Accession #s   rightarrow Product Desc   rightarrow Diseases/Tissues/Pathways   rightarrow Applications   rightarrow References 
 Product Name   

Vascular Endothelial Growth Factor receptor-3 (FLT4), Recombinant Protein

★Popular Item★
 Also Known As   

Recombinant Human Vascular Endothelial Growth Factor receptor-3

 Product Synonym Names    FLT4 Human; Vascular Endothelial Growth Factor Receptor-3 Human Recombinant; Tyrosine-protein kinase receptor FLT4; PCL; FLT41; FMS-LIKE TYROSINE KINASE 4; VEGFR-3; VEGFR3
 Product Gene Name   

FLT4 recombinant protein

[Similar Products]
 Research Use Only    For Research Use Only. Not for use in diagnostic procedures.
Table BarTOPTable Bar
 OMIM    136352
 3D Structure    ModBase 3D Structure for P35916
Section Bar
 Host    Insect Cells
Section Bar
 Purity/Purification    Greater than 90.0% as determined by(a)Analysis by RP-HPLC. (b)Analysis by SDS-PAGE.
 Form/Format    FLT4 was lyophilized from a concentrated (1 mg/ml) sterile solution containing 1x PBS.
Sterile Filtered White lyophilized (freeze-dried) powder.
Section Bar
 Solubility    It is recommended to reconstitute the lyophilized FLT4 in sterile water not less than 100 ug/ml, which can then be further diluted to other aqueous solutions.
 Biological Activity    Measured by its ability to bind recombinant rat VEGF-C in a functional solid phase binding assay. Immobilised recombinant human VEGFR-3/FLT-4 at 5 ug/ml can bind recombinant rat VEGF-C in a linear range of 8-500 ng/ml.
Section Bar
 Preparation and Storage    Lyophilized FLT4 although stable at room temperature for 3 weeks, should be stored desiccated below -18 degree C. Upon reconstitution FLT4 should be stored at 4 degree C between 2-7 days and for future use below -18 degree C.For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Please prevent freeze-thaw cycles.
 Other Notes    Small volumes of FLT4 recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Table BarTOPTable Bar
 

Related Product Information for FLT4 recombinant protein

   Description: Soluble FLT4 Human Recombinant fused with a carboxy-terminal 6X histidine-tag produced in baculovirus is a monomeric, glycosylated, polypeptide containing the extracellular part, 25-774 amino acids and having a total molecular mass of 120 kDa. The soluble receptor protein contains only the first 7 extracellular domains, which contain all the information necessary for ligand binding. The FLT4 is purified by proprietary chromatographic techniques.

Introduction: All three VEGF receptors belong to the class III subfamily of receptor tyrosine kinases (RTKs) characterised by the seven immunoglobulin-like loops in the extracellular domain. The expression of VEGFR-1 to -3 is almost exclusively restricted to hematopoietic precursor cells, vascular and lymphatic endothelial cells and to the monocyte/macrophage lineage. They play key roles in vasculogenesis, hematopoiesis, angiogenesis and lymphangiogenesis. The FLT-4 cDNA encodes a 1298 amino acid (aa) residue precursor protein with a 23 aa residue signal peptide. Mature VEGFR-3/FLT-4 is composed of a 751 aa residue extracellular domain, a 22 aa transmembrane domain and a 482 aa residue cytoplasmic domain. Both VEGF family members VEGF-C and VEGF-D have been shown to bind and activate VEGFR-3/FLT-4. The Flt-4 gene is widely expressed in the early embryo but becomes restricted to the lymphatic endothelial a latter stages of development. It is important for lymphangiogenesis.
 Product Categories/Family for FLT4 recombinant protein    PROTEIN KINASES; Enzymes; VEGF Receptors
NCBI/Uniprot data below describe general gene information for FLT4. It may not necessarily be applicable to this product.
 NCBI GI #    103472027
 NCBI GeneID    2324
 NCBI Accession #    NP_002011.2 [Other Products]
 NCBI GenBank Nucleotide #    NM_002020.4 [Other Products]
Section Bar
 UniProt Primary Accession #    P35916 [Other Products]
 UniProt Secondary Accession #    Q16067; Q86W07; Q86W08; A8K6L4; B5A926 [Other Products]
 UniProt Related Accession #    P35916; AAB23636 [Other Products]
 Molecular Weight    93,174 Da
Table BarTOPTable Bar
 NCBI Official Full Name    vascular endothelial growth factor receptor 3 isoform 2
 NCBI Official Synonym Full Names    fms-related tyrosine kinase 4
 NCBI Official Symbol    FLT4 [Similar Products]
 NCBI Official Synonym Symbols   
PCL; FLT41; LMPH1A; VEGFR3
[Similar Products]
 NCBI Protein Information    vascular endothelial growth factor receptor 3; FLT-4; VEGFR-3; fms-like tyrosine kinase 4; soluble VEGFR3 variant 1; soluble VEGFR3 variant 2; soluble VEGFR3 variant 3; tyrosine-protein kinase receptor FLT4
 UniProt Protein Name    Vascular endothelial growth factor receptor 3
 UniProt Synonym Protein Names   
Fms-like tyrosine kinase 4; FLT-4; Tyrosine-protein kinase receptor FLT4
 Protein Family    Vascular endothelial growth factor receptor
 UniProt Gene Name    FLT4 [Similar Products]
 UniProt Synonym Gene Names    VEGFR3; VEGFR-3; FLT-4 [Similar Products]
 UniProt Entry Name    VGFR3_HUMAN
Section Bar
 NCBI Summary for FLT4    This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008]
Section Bar
 UniProt Comments for FLT4    VEGFR3: Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFC and VEGFD, and plays an essential role in adult lymphangiogenesis and in the development of the vascular network and the cardiovascular system during embryonic development. Promotes proliferation, survival and migration of endothelial cells, and regulates angiogenic sprouting. Signaling by activated FLT4 leads to enhanced production of VEGFC, and to a lesser degree VEGFA, thereby creating a positive feedback loop that enhances FLT4 signaling. Modulates KDR signaling by forming heterodimers. The secreted isoform 3 may function as a decoy receptor for VEGFC and/or VEGFD and play an important role as a negative regulator of VEGFC-mediated lymphangiogenesis and angiogenesis. Binding of vascular growth factors to isoform 1 or isoform 2 leads to the activation of several signaling cascades; isoform 2 seems to be less efficient in signal transduction, because it has a truncated C-terminus and therefore lacks several phosphorylation sites. Mediates activation of the MAPK1/ERK2, MAPK3/ERK1 signaling pathway, of MAPK8 and the JUN signaling pathway, and of the AKT1 signaling pathway. Phosphorylates SHC1. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3- kinase. Promotes phosphorylation of MAPK8 at 'Thr-183' and 'Tyr- 185', and of AKT1 at 'Ser-473'. Interacts with VEGFC and VEGFD. Monomer in the absence of bound VEGFC or VEGFD. Homodimer in the presence of bound VEGFC or VEGFD. Can also form a heterodimer with KDR. Interacts with PTPN14; the interaction is enhanced by stimulation with VEGFC. Interacts with CRK, GRB2, PTK2/FAK1, SHC1, PIK3R1 and PTPN11/SHP- 2. Identified in a complex with SRC and ITGB1. Detected in endothelial cells. Widely expressed. Detected in fetal spleen, lung and brain. Detected in adult liver, muscle, thymus, placenta, lung, testis, ovary, prostate, heart, and kidney. Present in an inactive conformation in the absence of bound ligand. Binding of VEGFC or VEGFD leads to dimerization and activation by autophosphorylation on tyrosine residues. Inhibited by MAZ51. Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily. 3 isoforms of the human protein are produced by alternative splicing.

Protein type: Membrane protein, integral; Protein kinase, tyrosine (receptor); Kinase, protein; EC 2.7.10.1; Protein kinase, TK; TK group; VEGFR family

Chromosomal Location of Human Ortholog: 5q35.3

Cellular Component: integral to plasma membrane; cytoplasm; extracellular region; plasma membrane; nucleus; receptor complex

Molecular Function: vascular endothelial growth factor receptor activity; protein binding; growth factor binding; transmembrane receptor protein tyrosine kinase activity; protein phosphatase binding; ATP binding

Biological Process: peptidyl-tyrosine phosphorylation; protein amino acid autophosphorylation; positive regulation of JNK cascade; vasculature development; positive regulation of MAPKKK cascade; positive regulation of cell proliferation; lymphangiogenesis; blood vessel morphogenesis; positive regulation of endothelial cell proliferation; sprouting angiogenesis; positive regulation of protein amino acid phosphorylation; vascular endothelial growth factor receptor signaling pathway; lymph vessel development; transmembrane receptor protein tyrosine kinase signaling pathway; negative regulation of apoptosis

Disease: Hemangioma, Capillary Infantile; Lymphedema, Hereditary, Ia
Table BarTOPTable Bar
 Research Articles on FLT4    1. increased expression in tumors of Ang-2 may individually, or in combination with VEGFR-3, predict poor prognosis of OSCC
Table BarTOPTable Bar
 Precautions    All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
 Disclaimer    While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Table BarTOPTable Bar
Products associated with FLT4 recombinant proteinPathways associated with FLT4 recombinant protein
 Reference Product  PubMed Publications
 KDR recombinant protein  >46 publications with FLT4 and KDR
 VEGFC recombinant protein  >36 publications with FLT4 and VEGFC
 VEGFA recombinant protein  >18 publications with FLT4 and VEGFA
 FIGF recombinant protein  >6 publications with FLT4 and FIGF
 GRB2 recombinant protein  >4 publications with FLT4 and GRB2
 PGF recombinant protein  >3 publications with FLT4 and PGF
 VEGFB recombinant protein  >3 publications with FLT4 and VEGFB
 SHC1 recombinant protein  >1 publications with FLT4 and SHC1
 Products by Pathway  Pathway Diagram
 Cytokine-cytokine Receptor Interaction Pathway antibodies  Cytokine-cytokine Receptor Interaction Pathway Diagram
 Cytokine-cytokine Receptor Interaction Pathway antibodies  Cytokine-cytokine Receptor Interaction Pathway Diagram
 Focal Adhesion Pathway antibodies  Focal Adhesion Pathway Diagram
 Focal Adhesion Pathway antibodies  Focal Adhesion Pathway Diagram
 PI3K-Akt Signaling Pathway antibodies  PI3K-Akt Signaling Pathway Diagram
 PI3K-Akt Signaling Pathway antibodies  PI3K-Akt Signaling Pathway Diagram
 Rap1 Signaling Pathway antibodies  Rap1 Signaling Pathway Diagram
 Rap1 Signaling Pathway antibodies  Rap1 Signaling Pathway Diagram
 Ras Signaling Pathway antibodies  Ras Signaling Pathway Diagram
 Signal Transduction Pathway antibodies  Signal Transduction Pathway Diagram
Diseases associated with FLT4 recombinant proteinOrgans/Tissues associated with FLT4 recombinant protein
 Disease Name  Pubmed Publications
 Lymphedema Antibodies  >29 publications with FLT4 and Lymphedema
 Carcinoma Antibodies  >19 publications with FLT4 and Carcinoma
 Edema Antibodies  >10 publications with FLT4 and Edema
 Neoplasms, Experimental Antibodies  >7 publications with FLT4 and Neoplasms, Experimental
 Adenocarcinoma Antibodies  >7 publications with FLT4 and Adenocarcinoma
 Leukemia, Myeloid, Acute Antibodies  >4 publications with FLT4 and Leukemia, Myeloid, Acute
 Inflammation Antibodies  >4 publications with FLT4 and Inflammation
 Kidney Diseases Antibodies  >3 publications with FLT4 and Kidney Diseases
 Breast Neoplasms Antibodies  >3 publications with FLT4 and Breast Neoplasms
 Hypertension Antibodies  >2 publications with FLT4 and Hypertension
 Organ/Tissue Name  Pubmed Publications
 Vascular Antibodies  >126 publications with FLT4 and Vascular
 Embryonic Tissue Antibodies  >19 publications with FLT4 and Embryonic Tissue
 Heart Antibodies  >15 publications with FLT4 and Heart
 Lung Antibodies  >15 publications with FLT4 and Lung
 Placenta Antibodies  >14 publications with FLT4 and Placenta
 Muscle Antibodies  >12 publications with FLT4 and Muscle
 Bone Antibodies  >7 publications with FLT4 and Bone
 Kidney Antibodies  >7 publications with FLT4 and Kidney
 Lymph Node Antibodies  >6 publications with FLT4 and Lymph Node
 Brain Antibodies  >5 publications with FLT4 and Brain
Table BarTOPTable Bar
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions